PRS60 IMPACT of Health Technology Assessment (HTA) Recommendations on the Use of Fixed-Dose Combination (FDC) Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Health Technology Assessment ◽

Triple Therapy ◽

Pulmonary Disease ◽

Technology Assessment ◽

Health Technology ◽

Fixed Dose ◽

Chronic Obstructive ◽

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease

Journal of Market Access & Health Policy ◽

10.1080/20016689.2021.1929757 ◽

2021 ◽

Vol 9 (1) ◽

pp. 1929757

Author(s):

Jennifer Cook ◽

Chloe Bloom ◽

Jen Lewis ◽

Zoe Marjenberg ◽

Jaime Hernando Platz ◽

...

Keyword(s):

Health Technology Assessment ◽

Triple Therapy ◽

Technology Assessment ◽

Health Technology ◽

Prescribing Patterns ◽

Fixed Dose ◽

Chronic Obstructive ◽

Usability and Cost-of-Usability of Three Dry-Powder Inhalers (DPIs) in Patients with Chronic Obstructive Pulmonary Disease (COPD): May These Variables Influence the Health Technology Assessment of DPIs?

Chronic Obstructive Pulmonary Disease Open Access ◽

10.21767/2572-5548.100012 ◽

2016 ◽

Vol 01 (02) ◽

Author(s):

Roberto W Dal Negro ◽

Massimiliano Povero

Keyword(s):

Health Technology Assessment ◽

Pulmonary Disease ◽

Technology Assessment ◽

Health Technology ◽

Chronic Obstructive ◽

Dry Powder Inhalers ◽

Dry Powder ◽

Obstructive Pulmonary Disease

Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.776539 ◽

2013 ◽

Vol 14 (6) ◽

pp. 775-781 ◽

Cited By ~ 20

Author(s):

Mario Cazzola ◽

Paola Rogliani ◽

Maria Gabriella Matera

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Aclidinium Bromide ◽

Dose Combination ◽

Formoterol Fumarate

Safety of once-daily tiotropium and olodaterol fixed-dose combination via the Respimat in chronic obstructive pulmonary disease in two 1-year studies

Pneumologie ◽

10.1055/s-0035-1544638 ◽

2015 ◽

Vol 69 (S 01) ◽

Cited By ~ 1

Author(s):

R Buhl ◽

R Abrahams ◽

L Bjermer ◽

E Derom ◽

M Fležar ◽

...

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Once Daily ◽

Fixed‐dose combination of umeclidinium and vilanterol for patients with chronic obstructive pulmonary disease: A systematic review

The Clinical Respiratory Journal ◽

10.1111/crj.13073 ◽

2019 ◽

Vol 13 (11) ◽

pp. 663-673

Author(s):

Wijdan H. Ramadan ◽

Sarah Al Masri ◽

John Rizk

Keyword(s):

Systematic Review ◽

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease ◽

10.1177/1753465815575254 ◽

2015 ◽

Vol 9 (2) ◽

pp. 56-68

Author(s):

K. Suresh Babu ◽

Jaymin B. Morjaria

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Aclidinium Bromide ◽

Dose Combination ◽

Formoterol Fumarate

The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease

Pulmonary Pharmacology & Therapeutics ◽

10.1016/j.pupt.2015.04.002 ◽

2015 ◽

Vol 32 ◽

pp. 53-59 ◽

Cited By ~ 55

Author(s):

Kai-Michael Beeh ◽

Jan Westerman ◽

Anne-Marie Kirsten ◽

Jacques Hébert ◽

Lars Grönke ◽

...

Keyword(s):

Lung Function ◽

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Once Daily ◽

Dose Combination ◽

Function Profile

Orally inhaled fixed-dose combination products for the treatment of asthma and chronic obstructive pulmonary disease: not simple math

Therapeutic Delivery ◽

10.4155/tde.14.4 ◽

2014 ◽

Vol 5 (3) ◽

pp. 297-317 ◽

Cited By ~ 9

Author(s):

Jason D Ehrick ◽

Jennifer Wylie ◽

Adrian P Goodey ◽

Ying Li ◽

Oscar Liu ◽

...

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ◽

10.15326/jcopdf.6.3.2018.0160 ◽

2019 ◽

Vol 6 (3) ◽

pp. 221-232

Author(s):

Charlie Strange ◽

Valery Walker ◽

Junliang Tong ◽

Jonathan Kurlander ◽

Maureen Carlyle ◽

...

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Claims Analysis ◽

A Retrospective Claims Analysis of Dual Bronchodilator Fixed-Dose Combination Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ◽

10.15326/jcopdf.6.3.2018.06160 ◽

2019 ◽

Vol 6 (3) ◽

Author(s):

Charlie Strange ◽

Valery Walker ◽

Junliang Tong ◽

Jonathan Kurlander ◽

Maureen Carlyle ◽

...

Keyword(s):

Pulmonary Disease ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Chronic Obstructive ◽

Claims Analysis ◽